Jacobs Levy Equity Management, Inc Corcept Therapeutics Inc Transaction History

Jacobs Levy Equity Management, Inc

$23.9 Billion
Q3 2025

A detailed history of Jacobs Levy Equity Management, Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 3,828 shares of CORT stock, worth $289,167. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,828

Previous 455,451 99.16%

Holding current value

$289,167

Previous $33.4 Million 99.05%

% of portfolio

0.0%

Previous 0.14%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 17, 2025	SELL	$67.17 - $83.9 $30.3 Million - $37.9 Million	-451,623 Reduced 99.16%	3,828 $318,000
Q2 2025 Aug 14, 2025	SELL	$62.24 - $91.93 $55.7 Million - $82.2 Million	-894,231 Reduced 66.25%	455,451 $33.4 Million
Q1 2025 May 15, 2025	SELL	$49.85 - $114.22 $1.36 Million - $3.11 Million	-27,199 Reduced 1.98%	1,349,682 $154 Million
Q4 2024 Feb 14, 2025	BUY	$44.66 - $60.85 $6.84 Million - $9.32 Million	153,100 Added 12.51%	1,376,881 $69.4 Million
Q3 2024 Nov 14, 2024	BUY	$29.51 - $46.26 $10.4 Million - $16.3 Million	352,947 Added 40.53%	1,223,781 $56.6 Million

Q2 2024 Aug 14, 2024	BUY	$22.21 - $34.48 $3.1 Million - $4.81 Million	139,366 Added 19.05%	870,834 $28.3 Million
Q1 2024 May 15, 2024	BUY	$21.1 - $27.46 $15.4 Million - $20.1 Million	731,468 New	731,468 $18.4 Million
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $11.8 Million - $19.2 Million	-704,024 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$12.46 - $19.98 $2.06 Million - $3.3 Million	-165,376 Reduced 19.02%	704,024 $12.3 Million
Q2 2020 Aug 17, 2020	BUY	$11.0 - $18.26 $4.08 Million - $6.78 Million	371,270 Added 74.53%	869,400 $14.6 Million
Q1 2020 May 15, 2020	BUY	$10.11 - $14.04 $5.04 Million - $6.99 Million	498,130 New	498,130 $5.92 Million
Q1 2018 May 15, 2018	SELL	$14.59 - $25.5 $719,432 - $1.26 Million	-49,310 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$15.77 - $20.72 $465,215 - $611,240	29,500 Added 148.91%	49,310 $891,000
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $243,663 - $382,333	19,810	19,810 $382,000

Others Institutions Holding CORT

# of Institutions

480

Shares Held

80.5M

Call Options Held

599K

Put Options Held

710K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $8.09B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account

Jacobs Levy Equity Management, Inc Corcept Therapeutics Inc Transaction History